Work

Lapatinib and Obatoclax Kill Tumor Cells through Blockade of ERBB1/3/4 and through Inhibition of BCL-xL and MCL-1

Year: 2012

Type: article

Source: Molecular Pharmacology

DOI: 10.1124/mol.112.077586

Authors: Nichola Cruickshanks, Hossein A. Hamed, M. Danielle Bareford, Andrew Poklepovic, Paul B. Fisher, Steven Grant, Paul Dent

Institution: Virginia Commonwealth University

Language: English

Topic: Cell death mechanisms and regulation

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: U.S. Department of Defense, National Institutes of Health, National Cancer Institute, National Institute of Diabetes and Digestive and Kidney Diseases

Awards: G169079229, G1805530462, G2447325627, G2953226657, G3595794522, Signaling Pathways Regulating Epithelial Cell Survival, Pancreatic Cancer Management by Novel Gene Therapy & Dietary Agents, OSU-03012 therapy for glioblastoma, G6986738744, COMBINED INHIBITION OF CHK1 AND MEK1/2 LEADS TO TUMOR CELL DEATH IN VIVO, MDA-7: Novel Cancer Therapeutic Gene, G9000057114

OpenAlex ID: W2153215028

FWCI: 1.742

Cites: 46

Cited by: 24

Related to: 10